South Africa Antifungal Drugs Market Size & Outlook

The antifungal drugs market in South Africa is expected to reach a projected revenue of US$ 249.5 million by 2033. A compound annual growth rate of 5.8% is expected of South Africa antifungal drugs market from 2026 to 2033.
Revenue, 2025 (US$M)
$159.8
Forecast, 2033 (US$M)
$249.5
CAGR, 2026 - 2033
5.8%
Report Coverage
South Africa

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

South Africa antifungal drugs market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

South Africa antifungal drugs market highlights

  • The South Africa antifungal drugs market generated a revenue of USD 159.8 million in 2025 and is expected to reach USD 249.5 million by 2033.
  • The South Africa market is expected to grow at a CAGR of 5.8% from 2026 to 2033.
  • In terms of segment, azoles was the largest revenue generating drug class in 2025.
  • Echinocandins is the most lucrative drug class segment registering the fastest growth during the forecast period.


Antifungal drugs market data book summary

Market revenue in 2025USD 159.8 million
Market revenue in 2033USD 249.5 million
Growth rate5.8% (CAGR from 2026 to 2033)
Largest segmentAzoles
Fastest growing segmentEchinocandins
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationAzoles, Echinocandins, Polyenes, Allylamines
Key market players worldwideNovartis AG ADR, Pfizer Inc, Bayer AG, Sanofi SA, Merck KGaA, Merck & Co Inc, GlaxoSmithKline, Abbott Laboratories, Enzon Pharmaceuticals Inc, Astellas Pharma Inc, Glenmark Pharmaceuticals


Other key industry trends

  • In terms of revenue, South Africa accounted for 0.9% of the global antifungal drugs market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Middle East & Africa, Saudi Arabia antifungal drugs market is projected to lead the regional market in terms of revenue in 2033.
  • Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 394.1 million by 2033.

Azoles was the largest segment with a revenue share of 50.56% in 2025. Horizon Databook has segmented the South Africa antifungal drugs market based on azoles, echinocandins, polyenes, allylamines covering the revenue growth of each sub-segment from 2021 to 2033.


The Medicines and Related Substances Act (as amended), Act No. 101 of 1965 (the Medicines Act), and its Regulations govern the policies for authorization, costing, and reimbursement of pharmaceuticals, biologicals, and medical devices.

The Act and its Regulations are supplemented by Industry Rules and Guidelines. SAHPRA has made these regulations public. In accordance with this Section, the transparent pricing structure comprises a single exit price, which is the only one at which producers may sell prescription drugs and other Scheduled substances to anybody other than the state.

Medical schemes, which entail an undertaking of liability in exchange for a premium or contribution to make provisions for receiving any pertinent healthcare, are also available in South Africa. This responsibility extends to any provider or group of suppliers who provide a relevant health service on behalf of a medical scheme, the medical scheme itself, or in accordance with a contract with a medical scheme.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Antifungal Drugs Market Companies

Name Profile # Employees HQ Website
Glenmark Pharmaceuticals View profile 10001+ Andheri, Maharashtra, India, Asia http://www.glenmarkpharma.com
GlaxoSmithKline View profile 10001+ London, England, United Kingdom, Europe http://www.gsk.com
Astellas Pharma Inc View profile 14484 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, Japan, 103-8411 http://www.astellas.com
Enzon Pharmaceuticals Inc View profile 1 20 Commerce Drive, Suite 135, Cranford, NJ, United States, 07016 http://www.enzon.com
Bayer AG View profile 99723 Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 https://www.bayer.com
Merck & Co Inc View profile 72000 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 https://www.merck.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com
Novartis AG ADR View profile 76057 Lichtstrasse 35, Basel, Switzerland, 4056 https://www.novartis.com

South Africa antifungal drugs market size, by drug class, 2021-2033 (US$M)

South Africa Antifungal Drugs Market Outlook Share, 2025 & 2033 (US$M)

South Africa antifungal drugs market size, by drug class, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online